Connected Drug Delivery Devices Market Expected To Grow With USD 4.07 Billion By 2028

 San Francisco, 24 March 2021: The Report Connected Drug Delivery Devices Market Size, Share & Trends Analysis Report By Technology (Bluetooth, NFC), By Product (Connected Sensors, Integrated Connected Devices), By End User, And Segment Forecasts, 2021 - 2028

The global connected drug delivery devices market size is expected to reach USD 4.07 billion by 2028 registering a CAGR of 46.7%, according to a new report by Grand View Research, Inc. Factors contributing to the growth of this market include a rise in awareness about the adverse effects of non-adherence to medication and increased adoption of IoT, patient connectivity, and engagement. The Covid-19 pandemic has further accentuated the need for “contactless” services, thereby increasing the demand for connected drug delivery devices as well as providing lucrative growth opportunities in the coming years.

Connected drug delivery devices help physicians to monitor the compliance of patients to the therapy prescribed by them as well as to modify the treatment of the patient treatment as required. A growing number of initiatives to create awareness regarding the complexities caused by overdosage or underdosage of medicines is expected to promote the adoption of connected drug delivery devices.

Patients with chronic diseases, such as asthma and diabetes, are facing challenges in managing medications, adherence to prescriptions, visiting healthcare providers, and maintaining a balanced diet. Connected drug delivery devices can be useful for self-management. These devices can aid in patient adherence to prescribed treatments, which is likely to significantly increase their adoption.

Major market players are collaborating via partnerships to enhance their market presence. For instance, in July 2020, Teva Respiratory, LLC, a U.S.-based affiliate of Teva Pharmaceutical Industries Ltd., launched the ProAir Digihaler inhalation powder. The device is a digital rescue inhaler with built-in Bluetooth wireless technology sensors for the treatment or prevention of bronchospasm.

Access Research Report of Connected Drug Delivery Devices Market @ https://www.grandviewresearch.com/industry-analysis/connected-drug-delivery-devices-market

Connected Drug Delivery Devices Market Report Highlights

  • The connected sensors product segment dominated the overall market in 2020 and is projected to expand further at a steady CAGR from 2021 to 2028
  • The growth of this segment is attributed to the lower prices of connected sensors than integrated connected devices
  • North America held the dominant share in 2020 due to the quick adoption of the latest technologies as well as devices
  • The industry participants are focusing on investing in acquisitions, collaborations, product launches, and partnerships to gain a competitive edge
  • In June 2020, Propeller Health entered into a partnership with Novartis. Through this, Propeller’s digital health platform co-packaged Novartis’ Enerzair Breezhaler for effective treatment of asthmatic patients
  • The healthcare providers end-user segment accounted for the majority of the revenue share in 2020 owing to the high prevalence of various chronic diseases
  • The Bluetooth technology segment is expected to lead the global market, in terms of revenue share, owing to the easy availability and low price of this technology
  • Asia Pacific is anticipated to witness steady growth from 2021 to 2028 due to the presence of emerging economies like Japan and increasing healthcare expenditure

List of Key Players Connected Drug Delivery Devices Market

  • Propeller Health
  • Teva Pharmaceutical Industries Ltd.
  • BIOCORP
  • Merck KGaA
  • Adherium Ltd.
  • West Pharmaceutical Services, Inc.
  • Aterica
  • Phillips Medisize
  • FindAir
  • Elcam Medical

Access Press Release of Connected Drug Delivery Devices Market @ https://www.grandviewresearch.com/press-release/global-connected-drug-delivery-devices-market

 

Comments

Post a Comment

Popular posts from this blog

Asia Pacific PoC Diagnostics Market Growth Opportunities, Industry Analysis And Forecast: Grand View Research Inc.

Image
San Francisco, 18 March 2020 :  The Report   Asia Pacific PoC Diagnostics Market  Analysis And Segment Forecasts To 2020 The Asia Pacific point of care (PoC) diagnostics market is expected to reach USD 5,427.1 million by 2020, according to a new study by Grand View Research, Inc. Growing base of geriatric population and the ability to render immediate results and improve patient care coupled with rising market penetration of PACS (picture archiving and communication systems) and EMR (electronic medical records) are expected to drive demand over the next six years. Skilled staff shortages, especially pertaining to the field of diagnostics are also expected to accelerate the market penetration rates of PoC products, by expediting lab automation processes. Rising demand for home healthcare and other healthcare establishments catering to the elderly population and initiatives undertaken by governments to shorten hospital stays by establishing out-patient care models are also expect
Read more

Food Additives Market Size & Share Hit USD 55.53 Billion By 2022 : Grand View Research Inc.

Image
San Francisco, 17 October 2019:   The Report   Global Food Additives Market   Analysis By Product Flavors & Enhancers (Natural, Artificial), Sweeteners (High Intensity, HFCS), Enzymes, Emulsifiers (Mono, Di-Glycerides, Lecithin, Stearoyl Lactylates, Sorbitan Esters), Shelf-life Stabilizers, Fat Replacers (Protein, Starch)] And Segment Forecast To 2022 Global food additives market is expected to reach USD 55.53 billion by 2022, according to a new study by Grand View Research, Inc. Food & beverage industry growth in BRICS and Middle East on account of rising domestic consumption and increasing foreign direct investments is expected to augment market growth. Asia Pacific is expected to be one of the most promising markets on account of growing domestic consumption in China and India owing to population growth and new product launches by food & beverage manufacturers. Availability of raw materials such as sorbitol and lactic acid in China, Indonesia, and Malaysia in light o
Read more

Integration Platform as a Service Market Valuation Is Expected To Exceed USD 2.70 Billion By 2025: Grand View Research Inc.

Image
San Francisco, 18 March 2020 :  The Report   Integration Platform as a Service (IPaaS) Market  Analysis By Integration Type (API, Process, Application, Data), By Services, By Deployment (Cloud, On-Premise, Hybrid) By Region, And Segment Forecasts, 2018 – 2025 The global integration platform as a service (IPaaS) market is expected to reach USD 2.705.8 million by 2025, according to a new report by Grand View Research, Inc. Rising need of advanced systems to improve the process of deploying, developing, and managing enterprise applications globally has been a major factor driving market growth. In addition, recent developments in big data, cloud computing, and Internet of Things (IoT) within organizations’ processes also paved the way for greater development of IPaaS solutions. Integration Platform as a Service is an emerging technology where in the applications, process, data, and application programs are integrated. The integration enables enterprises to reduce the complexity
Read more